177 related articles for article (PubMed ID: 7283815)
21. Ocular penetration and efficacy of chloroethyldeoxyuridine against herpetic keratouveitis.
Maudgal PC; De Clercq E; Bernaerts R; Dieltiens M; Breemersch M; Van Eeckhoutte L
Invest Ophthalmol Vis Sci; 1986 Oct; 27(10):1453-8. PubMed ID: 3759363
[TBL] [Abstract][Full Text] [Related]
22. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil against acute herpes simplex virus keratitis and the establishment of latency: comparison with acyclovir and bromovinyldeoxyuridine.
Rajcáni J; Reefschläger J
Acta Virol; 1987 Aug; 31(4):329-39. PubMed ID: 2892382
[TBL] [Abstract][Full Text] [Related]
24. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene.
Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Seno T
Mol Pharmacol; 1985 Dec; 28(6):581-7. PubMed ID: 3001499
[TBL] [Abstract][Full Text] [Related]
25. Prophylaxis and therapy of experimental ocular herpes simplex. Comparison of idoxuridine, adenine arabinoside, and hypoxanthine arabinoside.
Pavan-Langston D; Langston RH; Geary PA
Arch Ophthalmol; 1974 Nov; 92(5):417-21. PubMed ID: 4611395
[No Abstract] [Full Text] [Related]
26. Selective antiherpetic activity of carbocyclic analogues of (E)-5-(2-halogenovinyl)-2'-deoxyuridines: dependence on specific phosphorylation by viral thymidine kinase.
De Clercq E; Balzarini J; Bernaerts R; Herdewijn P; Verbruggen A
Biochem Biophys Res Commun; 1985 Jan; 126(1):397-403. PubMed ID: 2982373
[TBL] [Abstract][Full Text] [Related]
27. Oral antiviral drugs in experimental herpes simplex keratitis.
Kaufman HE; Varnell ED; Centifanto-Fitzgerald YM; De Clercq E; Kissling GE
Antimicrob Agents Chemother; 1983 Dec; 24(6):888-91. PubMed ID: 6318664
[TBL] [Abstract][Full Text] [Related]
28. Herpes simplex acyclovir-resistant mutant in experimental keratouveitis.
Boisjoly HM; Park NH; Pavan-Langston D; De Clercq E
Arch Ophthalmol; 1983 Nov; 101(11):1782-6. PubMed ID: 6314952
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic potential of BVDU as an antiherpetic drug.
De Clercq E
Bull Soc Ophtalmol Fr; 1982; 82(6-7):913. PubMed ID: 7172397
[No Abstract] [Full Text] [Related]
30. Adenine arabinoside in idoxuridine unresponsive and intolerant herpetic keratitis.
Hyndiuk RA; Hull DS; Schultz RO; Chin GN
Am J Ophthalmol; 1975 Apr; 79(4):655-8. PubMed ID: 123413
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine in the treatment of experimental herpes simplex virus encephalitis in mice.
Park NH; Pavan-Langston D; de Clercq E
Antiviral Res; 1983 Mar; 3(1):7-15. PubMed ID: 6870230
[TBL] [Abstract][Full Text] [Related]
32. Carbocyclic 5-iodo-2'-deoxyuridine (C-IDU) and carbocyclic (E)-5-(2-bromovinyl)-2'-deoxyuridine (C-BVDU) as unique examples of chiral molecules where the two enantiomeric forms are biologically active: interaction of the (+)- and (-)-enantiomers of C-IDU and C-BVDU with the thymidine kinase of herpes simplex virus type 1.
Balzarini J; De Clercq E; Baumgartner H; Bodenteich M; Griengl H
Mol Pharmacol; 1990 Mar; 37(3):395-401. PubMed ID: 2156153
[TBL] [Abstract][Full Text] [Related]
33. Treatment of herpetic keratitis.
Blake J; Browne M
Doc Ophthalmol; 1977 Sep; 44(1):23-33. PubMed ID: 411644
[TBL] [Abstract][Full Text] [Related]
34. Antiviral agents in herpes simplex keratitis.
Raju VK
Indian J Ophthalmol; 1982 Jul; 30(4):209-11. PubMed ID: 6820003
[No Abstract] [Full Text] [Related]
35. Effect of iontophoretic and topical application of antiviral agents in treatment of experimental HSV-1 keratitis in rabbits.
Kwon BS; Gangarosa LP; Park NH; Hull DS; Fineberg E; Wiggins C; Hill JM
Invest Ophthalmol Vis Sci; 1979 Sep; 18(9):984-8. PubMed ID: 90030
[TBL] [Abstract][Full Text] [Related]
36. Newer compounds in therapy of herpes simplex keratitis.
Hyndiuk RA; Kaufman HE
Arch Ophthalmol; 1967 Nov; 78(5):600-5. PubMed ID: 4293002
[No Abstract] [Full Text] [Related]
37. Antiviral update.
Kaufman HE
Ophthalmology; 1979 Jan; 86(1):131-6. PubMed ID: 119198
[TBL] [Abstract][Full Text] [Related]
38. Acyclovir treatment of experimental herpetic keratitis in the rabbit eye.
Bauer DJ
Am J Med; 1982 Jul; 73(1A):109-11. PubMed ID: 7102698
[TBL] [Abstract][Full Text] [Related]
39. Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice.
de Clercq E; Zhang ZX; Sim IS
Antimicrob Agents Chemother; 1982 Sep; 22(3):421-5. PubMed ID: 7137983
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Wilber BA; Docherty JJ
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1743-7. PubMed ID: 8021603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
